| 131 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 132 |
1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
|
2018 |
| 133 |
1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
|
2018 |
| 134 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 135 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 136 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 137 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 138 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 139 |
Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX |
2018 |
| 140 |
Frequency of ABCB1 Polymorphisms in Breast Cancer Patients in South Egypt Cancer Institute by High-Resolution Melting Curve Analysis
(Pilot Study) |
2018 |
